Subjects: Drug Labeling -- standards and Muscular Dystrophy, Duchenne -- drug therapy / Dates by Range: 2000 and later - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Drug Labeling -- standards ✖ Subjects Muscular Dystrophy, Duchenne -- drug therapy ✖ Dates by Range 2000 and later ✖

1. Duchenne muscular dystrophy and related dystrophinopathies: developing drugs for treatment

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, February 2018
Subject(s):: Clinical Trials as Topic -- standards
Drug Evaluation -- standards
Muscular Dystrophies -- drug therapy
Muscular Dystrophy, Duchenne -- drug therapy
Drug Labeling -- standards
Drugs, Investigational
Research Design
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.